Malignant liver tumours include a wide range of primary and secondary tumours. Although
surgery remains the mainstay of curative treatment, modern therapies integrate a variety of …

Although surgical resection is the only treatment of choice that can offer prolonged survival
and a chance of cure in patients with colorectal liver metastases (CRLM), nearly 80% of …

Objective: The aim of this study was to evaluate the short-and long-term outcome of
associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for …

Objective: To evaluate the oncological outcome for patients with colorectal liver metastases
(CRLM) randomized to associating liver partition and portal vein ligation for staged …

Objective: The aim of this retrospective study was to compare portal vein embolization (PVE)
and radiologica simultaneous portohepatic vein embolization (RASPE) for future liver …

Objectives: To analyze long-term oncological outcome along with prognostic risk factors in a
large cohort of patients with colorectal liver metastases (CRLM) undergoing ALPPS …

Objective: To compare 2 techniques of remnant liver hypertrophy in candidates for extended
hepatectomy: radiological simultaneous portal vein embolization and hepatic vein …

Objective: Associating Liver Partition and Portal vein ligation for Staged hepatectomy
(ALPPS) has been tested in various indications and clinical scenarios, leading to steady …

Background To assess the safety and efficacy of liver venous deprivation (simultaneous
hepatic vein embolization with portal vein embolization) compared with portal vein …

Objective: The aim of this study was to use the concept of benchmarking to establish robust
and standardized outcome references after the procedure ALPPS (Associating Liver …